Inspire Investing’s Regenxbio RGNX Stock Holding History

Inspire Investing’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,367	Closed	-$307K	–	869
2023 Q2	$307K	Buy	15,367 +845	+6%	+$16.3K	0.04%	774
2023 Q1	$275K	Buy	+14,522	New	+$321K	0.03%	469

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Inspire Investing's RGNX Position: Q3 2023 in Review

Inspire Investing sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 15,367 shares — an estimated $307K sold.

Inspire Investing first reported a position in RGNX in Q1 2023 and held it in 2 quarters. The position peaked at $307K in Q2 2023. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

Inspire Investing reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
Inspire Investing sold 15,367 Regenxbio shares in Q3 2023, an estimated $307K.
Inspire Investing first reported a position in Regenxbio in Q1 2023 and held it in 2 quarters.
Inspire Investing's Regenxbio position peaked at $307K in Q2 2023.
159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Inspire Investing's 13F filing for Q3 2023, filed 26 Oct 2023.